Your Article Summary
See Latest ArticlesMethotrexate-Induced Hodgkin Disease in a Patient With Systemic Lupus Erythematosus
Journal of the American Osteopathic Association, 06/26/09
Sliesoraitis S et al. - The authors present a case of methotrexate-induced Hodgkin disease in a 48-year-old man with a history of systemic lupus erythematosus (SLE). Discontinuation of methotrexate facilitated Hodgkin disease reversal.
Sarunas Sliesoraitis, 06/27/09
| "Methotrexate-Induced Hodgkin Disease in a Patient With Systemic Lupus Erythematosus" is just a small report which I hope could lead to bigger future discoveries. Although so much has been achieved even in the last few years, there are several tumors waiting to be explored. EBV is one of the potential future targets for tumor treatment. If withdrawal of immune suppression leads to regression of tumor, then erradication or suppression of viral growth should potentially achieve more impressive results! Viral specific therapies rather than cell kill should lead to improved toxicity profile and improve ultimate survival. I do hope that you will enjoy our article. Thank you! Sarunas Sliesoraitis, DO, PharmD |
Related Articles
A Rare Presentation of Central Nervous System in a Pediatric Patient With Hodgkin Disease: Cavernous Sinus Syndrome
Journal of Pediatric Hematology/Oncology, 11/19/09
Relevance Score: 69%%
Primary cutaneous Hodgkins lymphoma
Clinical and Experimental Dermatology, 10/16/09
Relevance Score: 67%%
Reduced-intensity conditioned allogeneic haematopoietic stem cell transplantation results in durable disease-free and overall survival in patients with poor prognosis myeloid and lymphoid malignancies: Eighty-month follow-up
Bone Marrow Transplantation, 11/13/09
Relevance Score: 66%%
Hodgkins disease of appendix: report of a case
Colorectal Disease, 10/19/09
Relevance Score: 66%%
Musculoskeletal manifestations in patients with malignant disease
Clinical Rheumatology, 11/16/09
Relevance Score: 65%%
Today in Adverse Drug Reactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain
Journal of Orthopaedics and Traumatology, 11/24/09
Enzyme therapy in Fabry disease: severe adverse events associated with anti-agalsidase cross-reactive IgG antibodies
British Journal of Clinical Pharmacology, 11/24/09
Appraising the post-marketing safety of medicines: A description of national and international pharmacovigilance with a focus on medicines used in chronic pain
Current Anaesthesia and Critical Care, 11/24/09